Caxton Associates (UK)’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Sell
149,164
-23,897
-14% -$219K 0.03% 350
2026
Q1
$1.61M Buy
173,061
+92,870
+116% +$914K 0.04% 266
2025
Q4
$561K Buy
+80,191
New +$504K 0.01% 480
2025
Q3
Sell
-122,709
Closed -$587K 867
2025
Q2
$587K Buy
+122,709
New +$704K 0.01% 389

Other funds holding NEOG

Caxton Associates (UK)'s NEOG Position: Q2 2026 in Review

Caxton Associates (UK) reduced its Neogen (NEOG) stake by 14% in Q2 2026, selling an estimated $219K and leaving 149,164 shares worth $1.34M. The position accounts for 0.03% of the portfolio, ranked #350.

Caxton Associates (UK) first reported a position in NEOG in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.61M in Q1 2026. 316 funds tracked by Wall St. Rank hold NEOG as of Q2 2026.

  • Caxton Associates (UK) held 149,164 shares of Neogen worth $1.34M as of Q2 2026.
  • Caxton Associates (UK) sold 23,897 Neogen shares in Q2 2026, an estimated $219K.
  • Neogen made up 0.03% of Caxton Associates (UK)'s portfolio in Q2 2026, its #350 holding.
  • Caxton Associates (UK) first reported a position in Neogen in Q2 2025 and has held it in 4 quarters since.
  • Caxton Associates (UK)'s Neogen position peaked at $1.61M in Q1 2026.
  • 316 funds tracked by Wall St. Rank held Neogen as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.